| BMI | body mass index |
| CCK | Cholecystokinin |
| COPD | chronic obstructive pulmonary disease |
| FFAs | free fatty acids |
| GLP-1 | Glucagon-like peptide 1 |
| HF | heart failure |
| IFN-γ | interferon-γ |
| IL-1 | interleukin-1 |
| IL-6 | interleukin-6 |
| IR | insulin resistance |
| MHOB | Metabolically Healthy Obesity |
| MONW | Metabolically Obese Normal Weight |
| MUO | Metabolically Unhealthy Obesity |
| NFκB | Nuclear Factor kappa B |
| NMDA | N-methyl-d-aspartate |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| PGE2 | prostaglandin E2 |
| PPIs | proton pump inhibitors |
| PYY | Peptide YY |
| T2DM | type II diabetes mellitus |
| TNF-α | tumor necrosis factor- α |
| TRPM6 | transient receptor potential melastatin 6 |
| TRPM7 | transient receptor potential melastatin 7 |
| VDBP | vitamin D binding protein |